🧬 WHAT IS TIRZEPATIDE?
Tirzepatide is a dual GIP and GLP-1 receptor agonist.
Those are two signaling systems involved in metabolic regulation. Researchers have studied tirzepatide extensively for effects involving glucose regulation, appetite and food intake, body weight, and other metabolic outcomes.
Why is the “dual” part interesting?
Instead of acting through only GLP-1 signaling, tirzepatide activates both GIP + GLP-1 receptors. That gives researchers a way to study how the two incretin pathways work together.
FDA-approved tirzepatide medicines exist for specific medical indications. That approval applies to the regulated prescription products and their labeled uses — it should not be interpreted as applying to unapproved research products.
In simple terms: two metabolic signaling pathways, one molecule, and a large body of human clinical research.
Stay curious, research friends. 🧬